srcl-8k_20190108.htm     

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549 

FORM 8-K 

Current Report 

Pursuant to Section 13 or 15(d) 

of the Securities Exchange Act of 1934 

Date of Report (Date of earliest event reported): January 8, 2019 

Stericycle, Inc. 

(Exact name of registrant as specified in its charter) 

 [DATA_TABLE_REMOVED] 

28161 North Keith Drive 

Lake Forest, Illinois 60045 

(Address of principal executive offices including zip code) 

(847) 367-5910 

(Registrant’s telephone number, including area code) 

Not Applicable 

(Former name or former address, if changed since last report) 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CR 230.425) 

☐ Soliciting material pursuant to Rule 425 under the Securities Act (17 CFR 240.14a-12) 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). 

Emerging growth company ☐ 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

Item 5.02.  

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. 

On January 11, 2019, Stericycle, Inc. (the “Company”) announced that Ruth-Ellen Abdulmassih, Executive Vice President, Communications and Related Services, will be stepping down from her position effective as of January 31, 2019. Ms. Abdulmassih will remain in an advisory role with the Company for a period of time, to assist with a smooth transition of her responsibilities. 

Ms. Abdulmassih’s departure from the Company will not affect the Company’s previously announced process to pursue strategic alternatives for its non-core Communications and Related Services business. 

SIGNATURES 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. 

Dated: January 11, 2019  

Stericycle, Inc.   

By:  

 /s/ Daniel V. Ginnetti  

 Daniel V. Ginnetti  

 Executive Vice President and Chief Financial Officer